Market Value140,261,000
Total Holdings40
File Date2016-04-28
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AEGR / Aegerion Pharmaceuticals, Inc.
RPTP / Raptor Pharmaceutical Corp.
CERS / Cerus Corporation
PBYI / Puma Biotechnology, Inc.
ICPT / Intercept Pharmaceuticals Inc
ARAY / Accuray Incorporated
CHRS / Coherus Oncology, Inc.
PXD / Pioneer Natural Resources Company
98235T107 / Wright Medical Group N.V.
BIOL / BIOLASE, Inc.
NXTM / NxStage Medical, Inc.
SWN / Southwestern Energy Company
ROKA / Roka Bioscience, Inc.
GNCA / Genocea Biosciences Inc
BIIB / Biogen Inc.
MDVN / Medivation, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
/ Oxford Immunotec Global PLC
CALA / Calithera Biosciences, Inc.
QTNT / Quotient Ltd
TSRO / TESARO, Inc.
AGIO / Agios Pharmaceuticals, Inc.
COG / Cabot Oil & Gas Corp.
COLL / Collegium Pharmaceutical, Inc.
PQ / Petroquest Energy, Inc.
NSPR / InspireMD, Inc.
HNSN / Hansen Medical, Inc.
OMED / OptMed Inc
TTHI / Transition Therapeutics Inc.
CELGZ / Celgene Corporation Series A Contingent Value Rights
MRK / Merck & Co., Inc.
CLR / Continental Resources Inc (OKLA)
ECA / EnCana Corp.
GILD / Gilead Sciences, Inc.
MACK / Merrimack Pharmaceuticals, Inc.
CFRX / ContraFect Corp
SIEN / Sientra, Inc.
PTCT / PTC Therapeutics, Inc.
CELG / Celgene Corp.
PACB / Pacific Biosciences of California, Inc.
QDEL / QuidelOrtho Corporation
AWH / Aspira Women's Health Inc.
KURA / Kura Oncology, Inc.
AXDX / Accelerate Diagnostics, Inc.
YTEN / Yield10 Bioscience, Inc.
NBIX / Neurocrine Biosciences, Inc.
XNCR / Xencor, Inc.
EQT / EQT Corporation
MASI / Masimo Corporation
CORT / Corcept Therapeutics Incorporated